Qiagen INC:1110297 [23-013139]

Ended Purchase Order Awarded Last action

Contract number
75N90023P00844
Awardee
Awarding agency
Obligated
$10,064

Award facts

Contract value 100% obligated
$10,064.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germantown, MD, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and clinical care missions over the one year period of performance. No subcontractors or set aside designations were identified for this contract.

Quick answers

Who was awarded contract 75N90023P00844?

75N90023P00844 was awarded to Qiagen, LLC by NIH Clinical Center (National Institutes of Health) on September 29, 2023.

How much is contract 75N90023P00844 worth?

The government has obligated $10,064 on 75N90023P00844.

Was contract 75N90023P00844 competed?

The extent of competition for 75N90023P00844 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award